Kliničke studije za KOPB u državi Texas
25 studija za KOPB traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
- Houston15 studija
- Dallas12 studija
- El Paso5 studija
- McKinney5 studija
- Cypress4 studija
- Mesquite4 studija
- Sugar Land3 studija
- Denison3 studija
- Grand Prairie3 studija
- San Antonio3 studija
- Lewisville3 studija
- The Woodlands3 studija
Službeni tekst studije (engleski)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Abilene
- Research Site, Brownsville
- Research Site, Dallas
- i još 12
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Solace Clinical Research- Site Number : 8400087, Austin
- IntraCare- Site Number : 8400034, Dallas
- Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
- i još 7
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Horizon Clinical Research Group., Cypress
- Metroplex Pulmonary and Sleep Center, McKinney
- DM Clinical Research- Tomball, Tomball
U tijeku regrutacijaFaza 2
Od 40 do 85 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07684820A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50001, Boerne
U tijeku regrutacijaFaza 2
Od 40 do 80 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Premier Pulmonary Critical Care and Sleep, Denison
- Baylor College of Medicine Medical Center, Houston
- Prime Clinical Research - Lewisville, Lewisville
U tijeku regrutacijaFaza 2
Od 40 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Wellness Clinical Research - Allen- Site Number : 8400085, Allen
- REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
- Novel Research - Bellaire- Site Number : 8400116, Bellaire
- i još 17
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont
U tijeku regrutacijaFaza 4
Od 40 do 85 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07053423An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- University of Texas Southwestern, Dallas
U tijeku regrutacija
Od 40 do 80 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, McKinney
- WB Contracted Clinical Research Site, Waxahachie
U tijeku regrutacijaFaza 2
Od 40 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Boerne
- Research Site, Dallas
- Research Site, Denison
- i još 5
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Baylor College of Medicine, Houston
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Boerne
- Research Site, El Paso
- Research Site, Houston
- i još 6
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Dallas
- Research Site, Forney
- Research Site, Fort Worth
- i još 5
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06883305The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- The Lung & Sleep Institute of North Texas, North Richland Hills
U tijeku regrutacijaOpažajna studija
Od 40 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Ten20 Clinical Research, Carrollton
- Horizon Clinical Research Group, Cypress
- i još 4
U tijeku regrutacijaFaza 2/3
Od 35 do 80 godina · Oba spola · Ažurirano 31. kol 2026. · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 11. kol 2026. · NCT07555483STRIVE Post-Market Registry Study
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
- University of Texas Health Science Center at Houston, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 3. kol 2026. · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Dallas
- GSK Investigational Site, DeSoto
- GSK Investigational Site, Greenville
- i još 6
U tijeku regrutacijaFaza 3
Od 40 do 75 godina · Oba spola · Ažurirano 28. srp 2026. · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT05181826Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Houston Methodist/Primary Critical Care, Houston
U tijeku regrutacija
Od 40 do 84 godina · Oba spola · Ažurirano 24. tra 2026. · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, El Paso
- i još 5
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 9. tra 2026. · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Corsicana
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 8. lis 2025. · NCT06959095Interprofessional Pharmacogenomics (IPGx) Registry and Repository
- Texas A&M Family Care, Bryan
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 12. ruj 2025. · NCT06726590Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Horizon Clinical Research Group, Houston
- CHRISTUS Trinity Mother Frances Health System, Tyler
U tijeku regrutacijaOpažajna studija
Od 50 godina i više · Oba spola · Ažurirano 5. kol 2025. · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Respire Research Institute, Houston
U tijeku regrutacija
Od 30 godina i više · Oba spola · Ažurirano 6. velj 2025. · NCT05204888Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.